blood monitoring

Views & Analysis

Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care.

News

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.